Fernö M - Search Results

1

Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.

Berglund P, Stighall M, Jirström K, Rydén L, Fernö M, Nordenskjöld B, Landberg G. Berglund P, et al. Among authors: ferno m. J Clin Pathol. 2008 Feb;61(2):184-91. doi: 10.1136/jcp.2007.047688. Epub 2007 May 4. J Clin Pathol. 2008. PMID: 17483245 Clinical Trial.

2

Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.

Baldetorp B, Fernö M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Akerman M, Killander D. Baldetorp B, et al. Among authors: ferno m. Cytometry. 1992;13(6):577-85. doi: 10.1002/cyto.990130605. Cytometry. 1992. PMID: 1451590 Free article.

3

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.

Borg A, Baldetorp B, Fernö M, Olsson H, Sigurdsson H. Borg A, et al. Among authors: ferno m. Int J Cancer. 1992 Jul 9;51(5):687-91. doi: 10.1002/ijc.2910510504. Int J Cancer. 1992. PMID: 1612775

4

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Among authors: ferno m. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

5

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J. Sigurdsson H, et al. Among authors: ferno m. Br J Cancer. 1990 Nov;62(5):786-90. doi: 10.1038/bjc.1990.380. Br J Cancer. 1990. PMID: 2245171 Free PMC article.

6

Prognostic significance of estrogen and progesterone receptors in stage II breast cancer.

Rydén S, Fernö M, Borg A, Hafström L, Möller T, Norgren A. Rydén S, et al. Among authors: ferno m. J Surg Oncol. 1988 Apr;37(4):221-6. doi: 10.1002/jso.2930370402. J Surg Oncol. 1988. PMID: 3283457 Clinical Trial.

7

Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation.

Fernö M, Baldetorp B, Bendahl PO, Borg A, Ewers SB, Olsson H, Rydén S, Sigurdsson H, Killander D. Fernö M, et al. Breast Cancer Res Treat. 1995;36(1):23-34. doi: 10.1007/BF00690181. Breast Cancer Res Treat. 1995. PMID: 7579503 Clinical Trial.

8

Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group.

Fernö M, Baldetorp B, Borg A, Brouillet JP, Olsson H, Rochefort H, Sellberg G, Sigurdsson H, Killander D. Fernö M, et al. Eur J Cancer. 1994;30A(14):2042-8. doi: 10.1016/0959-8049(94)00307-q. Eur J Cancer. 1994. PMID: 7857700

9

Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.

Ewers SB, Attewell R, Baldetorp B, Borg A, Fernö M, Långström E, Killander D. Ewers SB, et al. Among authors: ferno m. Breast Cancer Res Treat. 1992;24(2):115-26. doi: 10.1007/BF01961244. Breast Cancer Res Treat. 1992. PMID: 8443399

10

Oestrogen receptor analysis of paraffin sections and cytosol samples of primary breast cancer in relation to outcome after adjuvant tamoxifen treatment. The South Sweden Breast Cancer Group.

Fernö M, Andersson C, Fallenius G, Idvall I. Fernö M, et al. Acta Oncol. 1996;35(1):17-22. doi: 10.3109/02841869609098474. Acta Oncol. 1996. PMID: 8619935 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters